Musculoskeletal disorders Clinical Trials in Torrance, CA
As of June 2026, 1 paid clinical trial is recruiting for Musculoskeletal disorders in Torrance, California. Musculoskeletal disorder trials investigate intra-articular therapies, biologics, and rehabilitation for osteoarthritis, rheumatoid arthritis, low back pain, fibromyalgia, and rotator cuff disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
1 clinical trial for Musculoskeletal disorders
·Clear filters·↓ Download CSVAbout research studies in Torrance
Torrance has approximately 188 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Top Research Study Locations in Torrance
Researchers run research studies in Torrance, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Torrance Memorial Physician Network - Cancer Care | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 22 |
| City of Hope South Bay | Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer | 19 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Chronic Limb-Threatening Ischemia, Recurrent B Acute Lymphoblastic Leukemia, Adrenal Gland Pheochromocytoma | 15 |
| Torrance Memorial Medical Center | Acute Myocardial Infarction (AMI), Aortic Stenosis, Bacterial Infection | 7 |
| Harbor-UCLA Medical Center | Acute Major Bleeding, Diabetes Mellitus, Type 1, End-Stage Renal Disease | 6 |
| Collaborative Neuroscience Research, LLC | Bipolar Disorder Type I With Mania, Bipolar Disorder Type I With Mania or Mania With Mixed Features, Obesity and Overweight | 4 |
| The Lundquist Institute | ASCVD, ASCVD Management, Atherosclerosis Cardiovascular Disease | 4 |
| The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 4 |
| Harbor UCLA Medical Center | Hepatocellular Carcinoma, Hypertension, Ketamine Infusion | 3 |
| Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center | Acute Myocardial Infarction, Diabetes Mellitus, Type 2, Heart Failure | 3 |
| Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center | Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities, Moderate Aortic Valve Stenosis, Peripheral Arterial Disease | 3 |
| Neurocrine Clinical Site | Schizophrenia, Tardive Dyskinesia | 3 |
| Breathe Clear Institute | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Chronic Rhinosinusitis Without Nasal Polyps | 2 |
| CS Cancer at the Hunt Cancer Center | Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Carcinoma | 2 |
| City of Hope at South Bay | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 2 |
| GSK Investigational Site | Multiple Myeloma, Neoplasms, Head and Neck | 2 |
| Hunt Cancer Institute, an Affiliate of CS Cancer | Early Stage Triple-Negative Breast Carcinoma, TNBC, TNBC - Triple-Negative Breast Cancer | 2 |
| Macula Retina Vitreous Institute | Epiretinal Membrane, Neovascular Age-related Macular Degeneration | 2 |
| Macula Retina Vitreous Research Institute | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA), Neovascular Age-related Macular Degeneration | 2 |
| The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente | B-Cell Non-Hodgkins Lymphoma, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | 2 |
| Torrance Memorial Physicians Network | Colorectal Neoplasms | 2 |
| UCLA Hematology/Oncology - Torrance | Cancer of the Prostate, Hormone Sensitive Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC) | 2 |
| 603, Harbor University of California Los Angeles Center CRS | Acute HIV Infection | 1 |
| Abcentra Investigational Site | Acute Coronary Syndromes, Atherosclerotic Coronary Vascular Disease, Coronary Arterial Disease (CAD) | 1 |
| Adverum Clinical Site 202 | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
Active & Upcoming Studies in Torrance (2026)
Recruiting trials in Torrance grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (63 active studies)
- Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product, MO-03, in Patients With Early Stage Triple Negative Breast Cancer · Phase 2 · Yuan Yuan
- A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression · Phase 3 · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Cardiovascular (17 active studies)
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure · Boston Scientific Corporation
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Mental health & behavior (10 active studies)
- A Study of Brenipatide in Adult Participants With Schizophrenia · Phase 2 · Eli Lilly and Company
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. · Phase 2 · LB Pharmaceuticals Inc.
Neurology & pain (10 active studies)
- Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults · Phase 2 · Mohsen Saidinejad
- A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · Bristol-Myers Squibb
Diabetes & metabolic (7 active studies)
Eye & vision (7 active studies)
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
- A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease · Phase 2 · Bausch & Lomb Incorporated
HIV / STI (3 active studies)
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
- Menopausal HT for Women Living With HIV (HoT) · Phase 4 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Vaccines (1 active study)
Common conditions studied in Torrance
- Breast Cancer (7 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Schizophrenia (5 active studies). Schizophrenia research tests muscarinic agonists, long-acting injectable antipsychotics, and cognitive remediation therapies.
- Stage IV Lung Cancer AJCC v8 (5 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Anatomic Stage I Breast Cancer AJCC v8 (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Coronary Artery Disease (4 active studies). Coronary artery disease research evaluates lipid-lowering therapies, anti-inflammatory agents, and new revascularization devices.
Leading research sponsors in Torrance
- NRG Oncology
- SWOG Cancer Research Network
- National Cancer Institute (NCI)
- AstraZeneca
- Eli Lilly and Company
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Torrance. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Torrance
Hipa.ai aggregates every recruiting study in Torrance from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Torrance?
There are approximately 188 recruiting clinical trials in Torrance, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Torrance pay participants?
Most recruiting trials in Torrance compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Torrance?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Torrance?
The most common conditions under active study in Torrance include Breast Cancer (7), Anatomic Stage II Breast Cancer AJCC v8 (5), Schizophrenia (5), Stage IV Lung Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Torrance?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Torrance on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Torrance?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Torrance?
Recruiting research sites in Torrance include Torrance Memorial Physician Network - Cancer Care, City of Hope South Bay, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Torrance right now?
The largest active categories in Torrance are Cancer & tumors (63), Cardiovascular (17), Mental health & behavior (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.